Manfred Huttinger

Title: Manfred Huttinger: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Huttinger is a renowned inventor based in Wien, DE. With a focus on pharmaceutical innovations, he has contributed significantly to the field through his inventive prowess. As a dedicated researcher at Hoechst Aktiengesellschaft, Huttinger has developed compounds that hold promise for treating lipid metabolism disorders.

Latest Patents

Manfred Huttinger holds a patent for "Soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl) - Soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl)pyrimidine-5-carboxylic acid N-methyl-N-(3-trifluoromethylphenyl)amide." This invention includes a detailed process for the preparation of these soluble salts, which are useful as pharmaceuticals and starting materials. The compounds developed by Huttinger enhance the treatment of lipid metabolism disorders by stimulating the hepatic LDL receptor and show potential in pharmaceutical applications.

Career Highlights

Huttinger's career is marked by his innovative research and contributions to the pharmaceutical sector. His work at Hoechst Aktiengesellschaft has been pivotal in the development of new solutions that address metabolic disorders. With one patented invention to his name, Huttinger showcases the impact inventors can have in advancing medical treatments.

Collaborations

Throughout his career, Manfred Huttinger has collaborated with notable coworkers like Klaus-Dieter Kampe and Ernold Granzer. These collaborations have enriched his research and have contributed to the successful development of compounds that target key health issues.

Conclusion

In conclusion, Manfred Huttinger is a distinguished inventor whose contributions to pharmaceutical chemistry are evident in his innovative patent and collaborative efforts. His work at Hoechst Aktiengesellschaft underscores the importance of advancements in medical science, aiming to improve health outcomes related to lipid metabolism disorders.